ADA Primer 2020

Dr.Jothydev Kesavadev was the speaker of ADA Primer 2020 convention on 3 October 2020 organized by Dr.Aravind Sosale. He spoke on 'FDA approved biosimilar insulins'- development and need of biosimilars, as a cost effective solution to save millions of precious lives; and on Biocon biosimilar glargine. The session was moderated by Dr.Anand Moses.

Obesity India 2020

15th AIAAROCON Annual Convention was conducted on 3 and 4 October 2020, digitally. Dr.Jothydev Kesavadev spoke on the topic 'Obesity Pharmacotherapy: Kal, Aaj or Kal' on 4 October 2020. Dr.Mahesh Mandot and Dr.Atul Mathur were the chairpersons of the session. Dr.Jothydev also chaired the session 'The tangled web of diabetes, obesity and cancer: An overview' on the same day.

Madhura Nakshathra sangamam - Type 1 Diabetes Program

P.Kesavadev Trust and Type 1 Diabetic Welfare Society jointly organized Madhura Nakshathra Sangamam, a virtual event to lay out knowledge on Type 1 diabetes, innovative treatments, glucometers, new technologies and care during COVID times on 27 September 2020.

Jothydev’s Diabetes Team consists of Doctors, Dieticians, Diabetes nurses, Diabetes educators etc. Dr.Jothydev Kesavadev, Chairman and managing director of Jothydev’s Diabetes Research centre, Dr.Arun Shankar, medical director, JDC, Ms.Gopika Krishnan, academic head, JDC, Dr.Sajna Shijin, Ms. Geethu Sanal, chief dietician, Ms.Akhila Manoj, Diabetes Nurse, Ms.Remya Jose, Diabetes Nurse and Ms Beena Chandran , Clinical Research Coordinator spoke at the event. Mr.Vijesh T.R, State President, Type 1 Diabetic Welfare Society, presided over the function. Mr.Abdul Jaleel, secretary, gave the welcome notes. The event was concluded by vote of thanks given by Ms.Sudha Sreejesh, advisory board member of welfare society.

Over 200 children and their families participated actively in the virtual event.

JPEF Mini CME 2020

Jothydev’s Professional Education Forum (JPEF) is purely a scientific platform for the knowledge update of doctors and their multi-disciplinary team to apply the technologies and skills in day to day clinical practice. JPEF in association with Kesavadev Trust is actively indulged in educating the doctors about the various aspects of management of diabetes since decades by conducting International and national diabetes conventions and monthly JPEF mini CMEs.

Due to the prevailing pandemic of COVID-19, JPEF Mini CME 2020 was conducted virtually, as education should not cease during these difficult times. The JPEF Mini CME was organized in a virtual platform on 9 October 2020, in association with Kesavadev Trust and Medical Association AMS Nemom Chapter. The theme of the digital convention was ‘Fighting COVID- Providing patient the best’.

JPEF Mini CME 2020 was conducted from 6:00 pm to 9:00 pm and was marked by 6 lectures. Welcome was by Ms.Gopika Krishnan, Academic Head Jothydev’s Diabetes Research Centres and Dr.Jothydev Kesavadev, Chairman and Managing Director, Jothydev’s Diabetes Research Centres.

The scientific session commenced with lecture by Dr.Sunil Prasobh P, Physician & Diabetologist, additional Prof. of Internal Medicine, Govt. Medical College, Kollam, who spoke on ‘Staging and treatment of COVID-19: October 2020 update’. The session was moderated by Dr.Sumesh Raj, Prof. of Internal Medicine & Diabetology Sree Gokulam Medical College.

This was followed by a momentary inaugural ceremony. The guest of the virtual event was Dr.Gopinathan Nair, President, Indian Medical Association, Nemom Chapter.

Next was a lecture by Dr.Jothydev Kesavadev on ‘Two upcoming launches in India: Rybelsus(oral semaglutide) and Libre-a teaser’, which was chaired by Ms.Gopika Krishnan. This session was succeeded by Dr.A.G. Unnikrishnan, CEO and Chief of Endocrinology, Chellaram Diabetes Institute, Pune, who spoke on ‘Tackling time in range with newer basal insulins’. Dr.Arun Shankar, Medical Director of Jothydev’s Diabetes Research Centres was the chairperson of the session.

The next three lectures were chaired by Dr.Mohanan Nair, Chairman IMA-AMS, Nemom Chapter and Dr.Prasanth Sankar, Consultant in Internal Medicine & Diabetes, MGM Muthoot Hospitals, Pathanamthitta.

The first talk of this session was ‘SGLT2i: evolving science in the space of CKD’ given by Dr.Georgi Abraham, Prof. of Medicine, Pondicherry Institute of Medical Science, Director, Nephrology, Madras Medical Mission, Chennai. Subsequently Dr.A.G. Unnikrishnan spoke about ‘CKD with diabetes: a case-based discussion’. The last talk of this session was given Dr.MadhuSreedhar, Director, NIMS Heart foundation, on ‘heart failure with CKD-A case-based approach and was followed by a panel discussion. The convention was concluded with a vote of thanks by Dr.Arun Shankar.

The Gold Summit

Dr.Jothydev Kesavadev spoke at The Gold Summit on 10 October 2020 on ‘Pioneering the change: Taking innovation to efficacy’, chaired by Dr.Sanjay Aggarwal and Dr.Bipin Sethi. Physicians from across India participated in the virtual summit.

An ounce of prevention is worth a pound of cure

Dr.Jothydev Kesavadev was the faculty at an international educational event for doctors ‘An ounce of prevention is worth a pound of cure along with Dr.Javed Butler from Mississippi, USA, Dr.Sachin Chittawar, Bhopal and Dr.Samit Ghosal, Kolkata. He lectured on ‘The changing lens in T2D management’ on 13 October 2020. Emerging data from Declare TIMI, DAPA CKD and DAPA HF were discussed.